Cited by 45Sexual Differentiation and DisordersAdrenal Hormones and DisordersBone health and osteoporosis research

Bone mineral density and bone turnover in Romanian children and young adults with classical 21-hydroxylase deficiency are influenced by glucocorticoid replacement therapy

Open access
Zimmermann, Anca, Sido, Paula Grigorescu, Schulze, Egbert, Al Khzouz, Camelia, Lazea, Cecilia, Coldea, Cristina, Weber, Matthias M.·2009·Clinical Endocrinology

Abstract

Summary: Objective It remains controversial if glucocorticoid replacement therapy impairs bone mineral density (BMD) in young patients with 21‐hydroxylase deficiency. We aimed to analyze the impact of treatment variables, phenotype and genotype on BMD and bone metabolism in these patients. Design Cross‐sectional study. Measurements Twenty‐eight Caucasian patients with classical 21‐hydroxylase deficiency (5–39 years). Clinical parameters, hormonal status, osteocalcin (OC), C‐terminal telopeptide of type I collagen (CTX), genotype and lumbar BMD (Z‐scores) were assessed. Cumulative and mean hydrocortisone equivalent doses were calculated for the entire treatment period. Results Patients with severely reduced BMD Z‐scores (≤–2·5 SD) had significantly higher mean/cumulative glucocorticoid doses compared to patients with moderately reduced (P = 0·003/P = 0·026) and normal Z‐scores (> –1 SD) (P = 0·005/P = 0·011). Mean hydrocortisone equivalent doses > 20 mg/m 2/day led to significantly lower lumbar BMD Z‐scores (–2·16 ± 1·4 SD) vs. doses ≤ 20 mg/m 2/day (–0·59 ± 1·25 SD) (P = 0·008). BMD correlated negatively with mean/cumulative glucocorticoid doses and treatment duration. OC (86·45 ± 37·45 ng/ml) and CTX (1·45 ± 0·43 ng/ml) were significantly increased compared to an age‐ and sex‐matched control group in patients with active growth; only CTX was slightly increased in patients who completed growth. Conclusions High cumulative and mean glucocorticoid doses negatively impact on BMD in children and young adults with classical 21‐hydroxylase deficiency. Substitution therapy should be adapted particularly at this life period to prevent bone loss.

Integrity signals

Registry

Crossref · 10.1111/j.1365-2265.2008.03518.x

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Zimmermann, A., Sido, P. G., Schulze, E., Al Khzouz, C., Lazea, C., Coldea, C., & Weber, M. M.
Affiliations
  • Johannes Gutenberg University Mainz (DE)
  • Iuliu Hațieganu University of Medicine and Pharmacy (RO)
Corresponding author
Zimmermann, Anca
Venue
Clinical Endocrinology
Publisher
Wiley
Published
2009-09-07
Volume
71
Issue
4
Pages
477-484
ISSN
  • 0300-0664 (ISSN-L)
  • 1365-2265
OpenAlex
W1507068805
Cited by
45
References
7
Citations by year
2026: 3 · 2025: 2 · 2024: 2 · 2023: 4 · 2022: 2 · 2021: 2 · 2020: 2 · 2019: 2 · 2018: 5 · 2016: 3 · 2015: 2 · 2014: 4 · 2012: 5
FWCI
0.96
Type
journal article
Language
en
Open access
Locations
  • Clinical Endocrinology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Sexual Differentiation and Disorders
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
  • Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
Keywords
21-hydroxylase deficiency, congenital adrenal hyperplasia, bone mineral density, glucocorticoid replacement therapy, hydrocortisone dose, bone turnover, osteocalcin, C-terminal telopeptide of type I collagen, children and young adults, bone loss prevention
MeSH terms
Adolescent, Adrenal Hyperplasia, Congenital, Adult, Bone and Bones, Child, Child, Preschool, Cross-Sectional Studies, Female, Glucocorticoids, Humans, Hydrocortisone, Male, Steroid 21-Hydroxylase, Bone Density, Osteocalcin, Hormone Replacement Therapy, Collagen Type I

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review